Aurum Ventures MKI
Overview
Aurum Ventures MKI is the venture capital arm of Morris Kahn, focusing on investments in the healthcare, life science, and technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nucleix | Dec 2021 | Series C Extension | Co-investor |
| Beyeonics | Oct 2021 | VC Round | Co-investor |
| Scopio Labs | Feb 2022 | Series C | Co-investor |
| LiveKidney.BIO | Nov 2018 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Aurum Ventures MKI based?
Aurum Ventures MKI is headquartered in Ramat Gan, Israel.
When was Aurum Ventures MKI founded?
Aurum Ventures MKI was founded in 2005.
How many portfolio companies does Aurum Ventures MKI have?
Aurum Ventures MKI has 4 portfolio companies in Caplight's dataset.
What are some companies in Aurum Ventures MKI's portfolio?
Portfolio companies visible on Caplight include Nucleix, Beyeonics, Scopio Labs, LiveKidney.BIO.
What was Aurum Ventures MKI's most recent investment shown here?
Aurum Ventures MKI's most recent investment in this portfolio sample was in Scopio Labs in 2022.
What sectors does Aurum Ventures MKI focus on?
Aurum Ventures MKI focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Aurum Ventures MKI focus on?
Aurum Ventures MKI typically invests at the MultiStage stage.